Status:
COMPLETED
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
Lead Sponsor:
Mati Therapeutics Inc.
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Eligibility Criteria
Inclusion
- Over 18 yrs with ocular hypertension or open-angle glaucoma
- Subjects who have a best-corrected visual acuity of 20/100 or better.
Exclusion
- Subjects who wear contact lenses.
- Uncontrolled medical conditions
- Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.
- Subjects who have a history of chronic or recurrent inflammatory eye disease.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT00820300
Start Date
January 1 2009
End Date
December 1 2009
Last Update
September 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menlo Park, California, United States, 94025